Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Dermatology

The Biology and Diagnosis of ACH

At a Glance

Acrodermatitis continua of Hallopeau (ACH) is a rare immune condition causing sterile blisters, nail damage, and bone loss on fingers and toes. Diagnosis requires ruling out infections through cultures, skin biopsies, X-rays, and sometimes genetic testing for IL36RN mutations.

Understanding how Acrodermatitis continua of Hallopeau (ACH) works biologically is the first step toward managing it. ACH is not just a surface skin issue; it is driven by a specific “glitch” in your immune system that causes persistent, sterile (non-infected) inflammation at the tips of your fingers and toes [1][2]. For an overview of this condition, return to the Home Page.

Hallmark Symptoms and Progression

ACH typically follows a chronic, relapsing path. It rarely goes away on its own and tends to progress through these stages:

  • Sterile Pustules: The disease begins with small, white, fluid-filled blisters (pustules) [1]. Unlike a typical infection, these pustules are “sterile,” meaning they do not contain bacteria or fungus [3].
  • Nail Destruction (Onychodystrophy): As the inflammation continues, it attacks the nail bed. This causes the nail to become thick, brittle, or eventually fall off entirely (onychodystrophy) [4][5].
  • Bone Loss (Acro-osteolysis): In long-term or severe cases, the chronic inflammation can actually reach the bone. This may lead to acro-osteolysis, where the bone at the very tip of the finger (the distal phalanx) begins to dissolve or “resorb” [6][7].

The Biology: An Immune System Overdrive

The “glitch” behind ACH happens in what doctors call the IL-1/IL-36 chemokine-neutrophil axis [8].

In a healthy body, a protein called IL-36 receptor antagonist (produced by the IL36RN gene) acts like a brake on a car, stopping inflammation once it’s no longer needed [9]. In many patients with ACH, this “brake” is broken due to a loss-of-function mutation [10].

Without this brake, the body keeps producing interleukin-36 (IL-36), a pro-inflammatory signal. This signal constantly recruits neutrophils (a type of white blood cell) to the skin [8][11]. These neutrophils cluster together to form the pustules you see on your skin [12].

Distinguishing ACH from “The Mimics”

Because ACH is rare, it is frequently misdiagnosed as more common conditions. A proper diagnosis must rule out these “mimics”:

  • Bacterial Paronychia: A common infection around the nail. Unlike ACH, this usually responds quickly to antibiotics and is often accompanied by significant swelling and heat [1].
  • Fungal Onychomycosis: A nail fungus. While it causes nail changes, it rarely produces the persistent white pustules seen in ACH.
  • Pompholyx (Dyshidrotic Eczema): This causes itchy blisters on the hands but does not typically lead to the bone loss or severe nail destruction seen in ACH.

Diagnostic Checklist

A definitive diagnosis of ACH requires more than just a visual check. Your medical team should perform a combination of the following:

  1. Cultures: Swabbing the pustules for bacteria and fungus to prove they are sterile [3].
  2. Skin Biopsy: A small sample of skin is taken. Pathologists look for Kogoj pustules (clusters of neutrophils in the upper skin layers), which are a strong hallmark indicator of the pustular psoriasis spectrum [2].
  3. Dermoscopy: A specialized magnifying tool used by dermatologists to see pustules hidden deep under thick, scaly skin [13].
  4. Imaging (X-ray): Essential to check for acro-osteolysis (bone resorption) in the fingertips [6].
  5. Genetic Testing: Specifically checking for mutations in the IL36RN gene. This is especially important if the disease seems to be spreading to other parts of your body [9][14].
  6. Blood Work: To check for systemic inflammation markers (like CRP or ESR) which might indicate the disease is becoming more generalized.

Once diagnosed, the next step is planning your Treatment Strategy and Management.

Common questions in this guide

What causes the blisters in ACH?
The blisters, or sterile pustules, in ACH are caused by an overactive immune system rather than an infection. A genetic mutation often removes the 'brake' on inflammation, causing white blood cells to constantly gather in the skin.
Will ACH cause me to lose my fingernails or toenails?
Chronic inflammation from ACH can severely damage the nail bed over time. If left unmanaged, this ongoing inflammation may lead to the nails becoming thick and brittle, or eventually falling off entirely.
Why do I need an X-ray for a skin condition?
In severe or long-term cases of ACH, chronic inflammation can reach the underlying bone and cause it to slowly dissolve. An X-ray allows your doctor to check for this bone loss, known as acro-osteolysis, in your fingertips or toes.
What does it mean if my biopsy report mentions Kogoj pustules?
A Kogoj pustule is a specific cluster of white blood cells found in the upper layers of the skin during a biopsy. Its presence is a strong hallmark indicator used by pathologists to help diagnose ACH and rule out other mimicking conditions.
Should I get genetic testing for ACH?
Genetic testing checks for mutations in the IL36RN gene, which are known to drive the unchecked inflammation in ACH. Your doctor may recommend this testing if the disease appears to be spreading or to help determine the most effective targeted treatment plan.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can we perform a bacterial and fungal culture to officially rule out an infection before starting systemic treatment?
  2. 2.Does my biopsy report mention 'Kogoj pustules' or 'psoriform hyperplasia'?
  3. 3.Should we perform an X-ray to check for any bone loss (acro-osteolysis) in my fingertips or toes?
  4. 4.Is genetic testing for the IL36RN mutation appropriate for me, and how would it change my treatment plan?
  5. 5.Could you use a dermatoscope to look for deeper pustules that might be hidden by the scaling skin?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report.

    Battista T, Guerrasio G, De Fata Salvatores G, et al.

    Dermatologic therapy 2022; (35(5)):e15383 doi:10.1111/dth.15383.

    PMID: 35174591
  2. 2

    Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort.

    Assan F, Husson B, Hegazy S, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2022; (36(9)):1578-1583 doi:10.1111/jdv.18127.

    PMID: 35366356
  3. 3

    Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.

    Galluzzo M, D'Adamio S, Teoli M, et al.

    Dermatologic therapy 2019; (32(3)):e12899 doi:10.1111/dth.12899.

    PMID: 30969010
  4. 4

    Successful treatment of severe acrodermatitis continua of hallopeau with Bimekizumab: A case report.

    Xu L, Li K, Mutter E, Langley A

    SAGE open medical case reports 2025; (13()):2050313X241311043 doi:10.1177/2050313X241311043.

    PMID: 39850643
  5. 5

    Acrodermatitis Continua of Hallopeau Successfully Treated with Ustekinumab: A Case Report and Literature Review.

    Shi L, Zeng L, Huang X, et al.

    Clinical, cosmetic and investigational dermatology 2023; (16()):951-957 doi:10.2147/CCID.S404860.

    PMID: 37051587
  6. 6

    [A man with a painful index finger].

    Hutting KH, Bouwer LR, Keukens FM

    Nederlands tijdschrift voor geneeskunde 2016; (160()):A9686.

    PMID: 26883842
  7. 7

    Acrodermatitis Continua of Hallopeau with Bone Resorption in an 8-Year-Old Patient: A Case Report.

    Alorainy M, Alshaya M, Al-Rikabi A, et al.

    Case reports in dermatology 2017; (9(3)):259-264 doi:10.1159/000485370.

    PMID: 29422844
  8. 8

    Genetic analysis of different subtypes of aseptic pustulosis in the Chinese population.

    Chen J, Xue X, Wang Z, et al.

    Clinical and experimental dermatology 2024; (49(10)):1217-1226 doi:10.1093/ced/llae144.

    PMID: 38651209
  9. 9

    Juvenile-onset pustular psoriasis: case series and literature review.

    Huang YW, Tsai TF

    The British journal of dermatology 2020; (182(3)):816-817 doi:10.1111/bjd.18473.

    PMID: 31483866
  10. 10

    The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab.

    Hawkes JE, Visvanathan S, Krueger JG

    Frontiers in immunology 2023; (14()):1292941 doi:10.3389/fimmu.2023.1292941.

    PMID: 38077370
  11. 11

    Pustular psoriasis as an autoinflammatory keratinization disease (AiKD): Genetic predisposing factors and promising therapeutic targets.

    Akiyama M

    Journal of dermatological science 2022; (105(1)):11-17 doi:10.1016/j.jdermsci.2021.11.009.

    PMID: 34973880
  12. 12

    Updated genetic background of generalized pustular psoriasis as an autoinflammatory keratinization disease.

    Akiyama M

    The Journal of dermatology 2025; (52(3)):400-407 doi:10.1111/1346-8138.17585.

    PMID: 39698752
  13. 13

    Dermoscopy in facilitating the recognition of acrodermatitis continua of Hallopeau.

    Errichetti E, Stinco G

    The Journal of dermatology 2017; (44(11)):e286-e287 doi:10.1111/1346-8138.13978.

    PMID: 28734002
  14. 14

    Clinical characteristics, genetics, comorbidities and treatment of palmoplantar pustulosis: A retrospective analysis of 66 cases in a single center in Taiwan.

    Huang CM, Tsai TF

    The Journal of dermatology 2020; (47(9)):1046-1049 doi:10.1111/1346-8138.15470.

    PMID: 32613680

This page explains the biology and diagnosis of Acrodermatitis continua of Hallopeau (ACH) for educational purposes. Always consult your dermatologist or healthcare provider for an official diagnosis and medical advice.

Get notified when new evidence is published on Acrodermatitis continua of Hallopeau.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.